Potential for primary prevention of Alzheimer's disease: an analysis of population-based data (Q30836810)

27 June 2017

0 references

Potential for primary prevention of Alzheimer's disease: an analysis of population-based data (English)

1 reference

27 June 2017

1 reference

1 reference

Sam Norton

0 references

Fiona E Matthews

0 references

Carol Brayne

1 reference

27 June 2017

Kristine Yaffe

1 reference

27 June 2017

Deborah E Barnes

1 reference

27 June 2017

publication date

1 August 2014

1 reference

27 June 2017

1 reference

27 June 2017

1 reference

27 June 2017

1 reference

27 June 2017

page(s)

788-794

1 reference

A commentary on studies presenting projections of the future prevalence of dementia

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Global prevalence of dementia: a Delphi consensus study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Forecasting the global burden of Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

The effect of dementia trends and treatments on longevity and disability: a simulation model based on the MRC Cognitive Function and Ageing Study (MRC CFAS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

The projected effect of risk factor reduction on Alzheimer's disease prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Depression as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Modeling the effect of Alzheimer's disease on mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Midlife obesity and dementia: meta-analysis and adjusted forecast of dementia prevalence in the United States and China

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Worldwide variability in physical inactivity a 51-country survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Exploring the impact of prevalence and mortality on incidence of dementia in the oldest old: the sensitivity of a deterministic approach

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

20-Year prevalence projections for dementia and impact of preventive policy about risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Confounding and bias in the attributable fraction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

Prevalence of dementia in a southern European population in two different time periods: the ZARADEMP Project.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970136-X

7 January 2021

10.1016/S1474-4422(14)70136-X

Identifiers

DOI

1 reference

27 June 2017

1 reference